Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm
暂无分享,去创建一个
Raziel A. Ordóñez | B. Clotet | R. Twyman | P. Christou | G. Farré | T. Capell | E. Vamvaka | J. Blanco | Luis M Molinos-Albert | J. Carrillo | R. Shattock | G. Khush | B. O’Keefe | A. Evans | Anna Canela-Xandri | L. M. Molinos-Albert | Abbey B. Evans
[1] G. Learn,et al. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. , 2016, The New England journal of medicine.
[2] B. Barkla,et al. Optimisation and standardisation of extraction and HPLC analysis of rice grain protein , 2016 .
[3] C. Delaugerre,et al. Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection? , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] J. Buyel,et al. Polyclonal antibodies for specific detection of tobacco host cell proteins can be efficiently generated following RuBisCO depletion and the removal of endotoxins. , 2016, Biotechnology journal.
[5] P. Christou,et al. Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro , 2016, Plant Cell Reports.
[6] P. Christou,et al. Rice endosperm is cost‐effective for the production of recombinant griffithsin with potent activity against HIV , 2016, Plant biotechnology journal.
[7] J F Buyel,et al. Extraction and downstream processing of plant-derived recombinant proteins. , 2015, Biotechnology advances.
[8] R. Twyman,et al. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. , 2015, Plant biotechnology journal.
[9] Michael S. Seaman,et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 , 2015, Nature.
[10] K. Ramessar,et al. Engineering soya bean seeds as a scalable platform to produce cyanovirin‐N, a non‐ARV microbicide against HIV , 2015, Plant biotechnology journal.
[11] Tiffany Tu,et al. Manufacturing Economics of Plant-Made Biologics: Case Studies in Therapeutic and Industrial Enzymes , 2014, BioMed research international.
[12] M. Moloney,et al. Plant molecular pharming for the treatment of chronic and infectious diseases. , 2014, Annual review of plant biology.
[13] R. Twyman,et al. Engineering metabolic pathways in plants by multigene transformation. , 2013, The International journal of developmental biology.
[14] P. Christou,et al. Seeds as a production system for molecular pharming applications: status and prospects. , 2013, Current pharmaceutical design.
[15] J. Ma,et al. Transformation of Althaea officinalis L. by Agrobacterium rhizogenes for the production of transgenic roots expressing the anti-HIV microbicide cyanovirin-N , 2013, Transgenic Research.
[16] B. Haynes,et al. HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.
[17] Jianjun Li,et al. Expression and characterization of recombinant human alpha-antitrypsin in transgenic rice seed. , 2013, Journal of biotechnology.
[18] Robin A. Weiss,et al. Neutralizing antibodies to HIV-1 induced by immunization , 2013, The Journal of experimental medicine.
[19] M. Ohnishi-Kameyama,et al. Evaluation of Extraction Solutions for Biochemical Analyses of the Proteins in Rice Grains , 2013, Bioscience, biotechnology, and biochemistry.
[20] M. Swanson,et al. Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains. , 2012, AIDS Research and Human Retroviruses.
[21] E. Rybicki,et al. Plant made anti-HIV microbicides—A field of opportunity , 2012, Biotechnology Advances.
[22] L. Morris,et al. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. , 2012, Virology.
[23] R. Shattock,et al. Microbicides: topical prevention against HIV. , 2012, Cold Spring Harbor perspectives in medicine.
[24] Lang Shen,et al. Large-scale production of functional human serum albumin from transgenic rice seeds , 2011, Proceedings of the National Academy of Sciences.
[25] B. Clotet,et al. A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity. , 2011, Vaccine.
[26] Brigitte E. Sanders-Beer,et al. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus , 2011, Mucosal Immunology.
[27] S. Leelavathi,et al. Advances in plant molecular farming. , 2011, Biotechnology advances.
[28] A. Haase,et al. Early events in sexual transmission of HIV and SIV and opportunities for interventions. , 2011, Annual review of medicine.
[29] A. Gronenborn,et al. Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization* , 2010, The Journal of Biological Chemistry.
[30] P. Christou,et al. Can microbicides turn the tide against HIV? , 2010, Current pharmaceutical design.
[31] D. Meyerholz,et al. Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae , 2009, Journal of Virology.
[32] J. Ma,et al. Design, expression, and characterization of a multivalent, combination HIV microbicide , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] F. Ge,et al. Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fusion , 2009, Applied Microbiology and Biotechnology.
[34] Jürgen Breitenbach,et al. Transgenic multivitamin corn through biofortification of endosperm with three vitamins representing three distinct metabolic pathways , 2009, Proceedings of the National Academy of Sciences.
[35] David C. Montefiori,et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component , 2009, Proceedings of the National Academy of Sciences.
[36] A. Garg,et al. The Future of HIV Microbicides: Challenges and Opportunities , 2009, Antiviral chemistry & chemotherapy.
[37] Congyi Zheng,et al. A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery , 2008, Peptides.
[38] Congyi Zheng,et al. Oral administration of recombinant human granulocyte-macrophage colony stimulating factor expressed in rice endosperm can increase leukocytes in mice , 2008, Biotechnology Letters.
[39] P. Christou,et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission , 2008, Proceedings of the National Academy of Sciences.
[40] P. Christou,et al. Molecular pharming in cereal crops , 2008, Phytochemistry Reviews.
[41] R. Fischer,et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. , 2008, Plant biotechnology journal.
[42] J. Mcmahon,et al. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicide , 2007, Journal of medical primatology.
[43] I. Chaiken,et al. A recombinant allosteric lectin antagonist of HIV‐1 envelope gp120 interactions , 2007, Proteins.
[44] K. Van Laethem,et al. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. , 2007, Virology.
[45] I. McGowan. Microbicides: a new frontier in HIV prevention. , 2006, Biologicals : journal of the International Association of Biological Standardization.
[46] A. Gronenborn,et al. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition. , 2006, Protein engineering, design & selection : PEDS.
[47] Yang Liu,et al. Engineered Vaginal Lactobacillus Strain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-N , 2006, Antimicrobial Agents and Chemotherapy.
[48] J. Hartley,et al. Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture. , 2006, Protein expression and purification.
[49] J. Ma,et al. Transgenic plant production of Cyanovirin‐N, an HIV microbicide , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] J. Balzarini. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. , 2005, The Lancet. Infectious diseases.
[51] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[52] Stephen Lu,et al. Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain , 2005, Transgenic Research.
[53] R. Visser,et al. Particle bombardment and the genetic enhancement of crops: myths and realities , 2005, Molecular Breeding.
[54] Barry R O'Keefe,et al. Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.* , 2005, Journal of Biological Chemistry.
[55] I. Chaiken,et al. Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development. , 2005, Protein expression and purification.
[56] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[57] Paul Christou,et al. Transgene integration, organization and interaction in plants , 2003, Plant Molecular Biology.
[58] H. Katinger,et al. Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation , 2002, AIDS.
[59] A. Gronenborn,et al. Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts. , 2002, Protein expression and purification.
[60] M. Boyd,et al. The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 , 2002, AIDS.
[61] Carole A Bewley,et al. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. , 2002, Journal of molecular biology.
[62] Robert A. Rasmussen,et al. Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge , 2001, Journal of Virology.
[63] Q. Sattentau,et al. Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120 , 1999, Journal of Virology.
[64] L. Herrera-Estrella,et al. Transgenic Central American, West African and Asian Elite Rice Varieties Resulting from Particle Bombardment of Foreign DNA into Mature Seed-derived Explants Utilizing Three Different Bombardment Devices☆ , 1998 .
[65] K. Nagashima,et al. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding. , 1998, Biochemical and biophysical research communications.
[66] P. Christou,et al. An Efficient Rice Transformation System Utilizing Mature Seed-derived Explants and a Portable, Inexpensive Particle Bombardment Device , 1998, Transgenic Research.
[67] J. Sodroski,et al. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.
[68] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[69] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[70] L K Pannell,et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development , 1997, Antimicrobial agents and chemotherapy.
[71] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[72] J. Corvalan,et al. Immunoglobulins secreted by a hybrid-hybridoma: analysis of chain assemblies. , 1992, Hybridoma.
[73] P. Christou,et al. Production of Transgenic Rice (Oryza Sativa L.) Plants from Agronomically Important Indica and Japonica Varieties via Electric Discharge Particle Acceleration of Exogenous DNA into Immature Zygotic Embryos , 1991, Bio/Technology.
[74] Reed J. D. Sorensen,et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 , 2016, The lancet. HIV.
[75] R. Twyman,et al. Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12. , 2016, Plant biotechnology journal.
[76] P. Christou,et al. When more is better: multigene engineering in plants. , 2010, Trends in plant science.
[77] J. Mcmahon,et al. Multivalent interactions with gp120 are required for the anti‐HIV activity of Cyanovirin , 2009, Biopolymers.
[78] R. Burgess. Protein precipitation techniques. , 2009, Methods in enzymology.
[79] P. Christou,et al. The impact of selection parameters on the phenotype and genotype of transgenic rice callus and plants , 2005, Transgenic Research.
[80] P. Christou,et al. Multiple traits of agronomic importance in transgenic indica rice plants: analysis of transgene integration patterns, expression levels and stability , 2004, Molecular Breeding.
[81] R. Evangelista,et al. Process and Economic Evaluation of the Extraction and Purification of Recombinant β‐Glucuronidase from Transgenic Corn , 1998, Biotechnology progress.